Detalhe da pesquisa
1.
Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice.
J Antimicrob Chemother
; 78(10): 2591-2596, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671831
2.
Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients.
J Antimicrob Chemother
; 72(10): 2850-2856, 2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29091196
3.
High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use.
J Infect
; 85(3): 322-326, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700867
4.
Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
Clin Infect Dis
; 49(6): 892-900, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19663689
5.
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients.
AIDS Res Hum Retroviruses
; 22(4): 321-9, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16623634